Daré Bioscience (DARE) Stock Research

Today

Dare Bioscience reports Q2 EPS (20c), consensus (30c)

DARE

4:14 PM

Over a week ago

Dare Bioscience receives NIH funding award notice to advance DARE-HPV

DARE

May 26, 8:15 AM

Dare Bioscience initiates DARE-HPV clinical study

DARE

May 18, 8:07 AM

Dare Bioscience reports positive interim Phase 3 results for Ovaprene

DARE

May 12, 9:26 AM

Dare Bioscience receives NIH funding award notice for DARE-PTB1

DARE

Mar 16, 8:26 AM

Dare Bioscience announces FDA clearance of IND application for Dare-HPV

DARE

Feb 23, 8:17 AM

Dare announces availability of telehealth consultations for DARE to PLAY

DARE

Feb 11, 8:16 AM

Dare Bioscience announces providers in select states can prescribe DARE to PLAY

DARE

Dec 10, 8:07 AM

Dare Bioscience announces return of rights to Oveprene

Dec 1, 8:16 AM

Dare Bioscience receives $3.6M in additional grant funding

DARE

Nov 24, 8:29 AM

Dare Bioscience reports Q3 EPS (28c), consensus (38c)

DARE

Nov 13, 4:11 PM

Dare Bioscience to host webinar on the DARE to PLAY

DARE

Nov 11, 8:07 AM

Dare Bioscience to receive up to $300,000 to conduct landscape review

DARE

Nov 3, 8:15 AM

Dare Bioscience receives $4M non-dilutive grant installment

DARE

Oct 6, 8:16 AM

Dare Bioscience to receive up to $499,000 to support preeclampsia research

DARE

Sep 24, 8:05 AM

Maxim gets more bullish on Dare Bioscience, upgrades shares

DARE

Sep 4, 7:43 AM

No more stories